Hitomi Mori

629 total citations
36 papers, 464 citations indexed

About

Hitomi Mori is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hitomi Mori has authored 36 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Hitomi Mori's work include Cancer Cells and Metastasis (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Genomics and Diagnostics (4 papers). Hitomi Mori is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Genomics and Diagnostics (4 papers). Hitomi Mori collaborates with scholars based in Japan, United States and China. Hitomi Mori's co-authors include Takaharu Mizutani, Kazuhiko Takahashi, Makoto Kubo, Masaya Kai, Mai Yamada, Yoshinao Oda, Masafumi Nakamura, Masayuki Okido, Reiki Nishimura and Nobuyuki Arima and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Hitomi Mori

35 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitomi Mori Japan 12 216 132 102 65 58 36 464
Robyn T. Bilinski United States 8 130 0.6× 232 1.8× 69 0.7× 40 0.6× 24 0.4× 11 547
Minji Wei China 7 97 0.4× 168 1.3× 65 0.6× 18 0.3× 17 0.3× 13 345
Trong Thuan Ung South Korea 10 119 0.6× 241 1.8× 67 0.7× 51 0.8× 9 0.2× 14 422
How Sung Lee Singapore 10 110 0.5× 189 1.4× 56 0.5× 12 0.2× 17 0.3× 19 485
Yulian Xu China 15 217 1.0× 292 2.2× 60 0.6× 124 1.9× 14 0.2× 32 638
Ayesha Rashid Canada 9 126 0.6× 274 2.1× 117 1.1× 46 0.7× 35 0.6× 15 581
Cara L Crowley-Weber United States 7 132 0.6× 202 1.5× 44 0.4× 46 0.7× 9 0.2× 8 415
Jiake He China 12 138 0.6× 149 1.1× 51 0.5× 21 0.3× 10 0.2× 31 411
Valentina Aristarco Italy 12 240 1.1× 308 2.3× 142 1.4× 18 0.3× 14 0.2× 31 588
Ning Zhou China 10 75 0.3× 204 1.5× 68 0.7× 37 0.6× 15 0.3× 16 345

Countries citing papers authored by Hitomi Mori

Since Specialization
Citations

This map shows the geographic impact of Hitomi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Mori more than expected).

Fields of papers citing papers by Hitomi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Mori. The network helps show where Hitomi Mori may publish in the future.

Co-authorship network of co-authors of Hitomi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Mori. A scholar is included among the top collaborators of Hitomi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Mori. Hitomi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshitake, Ryohei, Hitomi Mori, Xiwei Wu, et al.. (2024). Molecular features of luminal breast cancer defined through spatial and single‐cell transcriptomics. Clinical and Translational Medicine. 14(1). e1548–e1548. 16 indexed citations
2.
Saeki, Kohei, Gregory Chang, Hitomi Mori, et al.. (2024). Perimenopausal and Menopausal Mammary Glands In A 4-Vinylcyclohexene Diepoxide Mouse Model. Journal of Mammary Gland Biology and Neoplasia. 29(1). 15–15.
3.
Watanabe, Chisato, Shujiro Hayashi, Hitomi Mori, & Ken Igawa. (2023). Erythema nodosum following COVID‐19 vaccination: A case report and literature review. SHILAP Revista de lepidopterología. 2(4). 932–936. 1 indexed citations
4.
Mori, Hitomi, Kohei Saeki, Gregory Chang, et al.. (2021). Influence of Estrogen Treatment on ESR1+ and ESR1− Cells in ER+ Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models. Cancers. 13(24). 6375–6375. 7 indexed citations
5.
Kai, Masaya, Makoto Kubo, Mai Yamada, et al.. (2021). Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients. Cancer Medicine. 10(5). 1605–1613. 10 indexed citations
6.
Wang, Xiaoqiang, et al.. (2020). White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft. The Journal of Nutritional Biochemistry. 89. 108580–108580. 21 indexed citations
7.
Kubo, Makoto, Masaya Kai, Hitomi Mori, et al.. (2020). Microsatellite instability in Japanese female patients with triple-negative breast cancer. Breast Cancer. 27(3). 490–498. 18 indexed citations
8.
Kubo, Makoto, Nami Yamashita, Hidetaka Yamamoto, et al.. (2020). Comprehensive molecular profiling broadens treatment options for breast cancer patients. Cancer Medicine. 10(2). 529–539. 29 indexed citations
9.
Mori, Hitomi, Makoto Kubo, Masaya Kai, et al.. (2019). T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer. Breast Cancer Research and Treatment. 176(3). 569–577. 23 indexed citations
10.
Mori, Hitomi, et al.. (2018). Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients. Anticancer Research. 38(7). 4381–4386. 2 indexed citations
11.
Mori, Hitomi, Makoto Kubo, Masaya Kai, et al.. (2018). BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations. Clinical Breast Cancer. 18(5). e1217–e1227. 8 indexed citations
12.
Kai, Masaya, et al.. (2018). QOL-enhancing surgery for patients with HER2-positive metastatic breast cancer. BMJ Supportive & Palliative Care. 9(2). 151–154. 3 indexed citations
13.
Kubo, Makoto, Masayo Umebayashi, Hitomi Mori, et al.. (2018). Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines. Anticancer Research. 38(7). 4273–4279. 28 indexed citations
14.
Mori, Hitomi, Makoto Kubo, Reiki Nishimura, et al.. (2016). BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer. PLoS ONE. 11(12). e0167016–e0167016. 21 indexed citations
15.
Matsushita, Yuki, Souichi Yanamoto, Shin‐ichi Yamada, et al.. (2015). Correlation between degree of bone invasion and prognosis in carcinoma of the mandibular gingiva: Soft tissue classification based on UICC classification. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 27(5). 631–636. 3 indexed citations
16.
Ito, Hideyuki, Hitomi Mori, Peng Li, et al.. (2013). Two New Monoterpene Glycosides from Qing Shan Lu Shui Tea with Inhibitory Effects on Leukocyte-Type 12-Lipoxygenase Activity. Molecules. 18(4). 4257–4266. 8 indexed citations
17.
Mori, Hitomi, et al.. (2007). The N-Terminal of Human UGT1A6 Is on the Outside, as Evidenced by ELISA with Autoantibody in Autoimmune Hepatitis Sera. Drug Metabolism Letters. 1(4). 261–266. 1 indexed citations
18.
Mori, Hitomi, Kazuhiko Takahashi, & Takaharu Mizutani. (2007). Interaction Between Valproic Acid and Carbapenem Antibiotics. Drug Metabolism Reviews. 39(4). 647–657. 69 indexed citations
19.
Tanaka, Takuji, Hiroki Makita, Natsuko Ino, et al.. (1997). Modifying effects of the arotinoid mofarotene (Ro 40–8757) on azoxymethane-induced rat colon and liver carcinogenesis. Hepatology Research. 7(1). 66–67. 2 indexed citations
20.
Kusaka, Takashi, et al.. (1975). Neuroendocrine control of the pituitary TSH secretion. VII. Effects of intraventricular and intraarterial administrations of 5-hydroxytryptophan (5-HTP) on rat pituitary TSH release.. PubMed. 21(2). 53–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robyn T. Bilinski Breakdown of academic impact, for papers by Minji Wei Breakdown of academic impact, for papers by Trong Thuan Ung Breakdown of academic impact, for papers by How Sung Lee Breakdown of academic impact, for papers by Yulian Xu Breakdown of academic impact, for papers by Ayesha Rashid Breakdown of academic impact, for papers by Cara L Crowley-Weber Breakdown of academic impact, for papers by Jiake He Breakdown of academic impact, for papers by Valentina Aristarco Breakdown of academic impact, for papers by Ning Zhou
Rankless by CCL
2026